Impact Factor for Five Years is 1.55 (2012 - 2016). IJPRT Re-launched from 2017, for more details visit www.ijprtonline.com

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
Article In Press
Analytical Method Development and Validation for the Simultaneous Estimation of Ambroxol Hydrochloride and Guaiphenesin in Syrup Dosage form by RP-HPLC
Role of NMDA receptor antagonist in ethanol withdrawal syndrome
STABILITY INDICATING LC-MS/MS METHOD FOR QUANTIFICATION OF IBRUTINIB IN HUMAN PLASMA
A review on drug: Amantadine
Chemopreventive and antioxidative activity of Carissa carandas extract against chemical induced skin tumorigenesis in mice
ROLE OF AMIODARONE IN ACUTE MYOCARDIAL INFARACTION INDUCED VENTRICULAR TACHYCARDIA IN PATIENTS WITH LEFT ANTERIOR DESCENDING ARTERY INVOLVEMENT
Extraction optimisation, fractionation, standardisation, in vitro antioxidant and anticholinesterase activity of fractions of Indian Propolis
Lung Cancer in Lifelong Never Smokers-Short Review
3D-Quantitative Structure Activity Relationship Study of Pyrazolothiazol-4-(5H)-One Derivatives as Epidermal Growth Factor Receptor Inhibitors
A Convenient strategy for the synthesis and characterisation of Biologically important Schiff bases encompassing Naphtho[2,1-b]thiophene carboxylic Acid
12
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
 

Article Detail

Label
Signaling pathways associated with liver cancer stem cell therapy

Author: SHILU MATHEW
Abstract: Liver cancer is a chronic disease with a poor outcome. Several progenitor markers/ hepatic stem are beneficial for isolating a subset of liver cells with stem cell features, called as cancer stem cells (CSCs). These cells are responsible for metastasis, tumor relapse, and chemoresistance. Liver CSCs dictate a hierarchical organization that shares both in tumorigenesis and organogenesis. A better understanding of the molecular signaling actions that regulate cellular hierarchy and success in defining key CSC-specific genes, which has opened up new avenues to accelerate the development of novel diagnostic and treatment strategies. This review highlights the molecular signaling networks associated with the pathogenesis of liver CSCs.
Keyword:
Download: Request For Article
 
INDEXED
Chemical Abstract Services
Scopus (Elsevier)
Embase(Elsevier)
Ulrich's International Periodical Dictionary
Indian Science Abstract
USER LOGIN
Username
Password
Login | Register
Forgot your password?
News & Events
Impact Factor for five years is 1.55 (2012 - 2016)
Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477
Impact Factor for five years is 1.3 (2010 - 2014)